SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001140361-21-016449
Filing Date
2021-05-07
Accepted
2021-05-07 16:30:17
Documents
4
Group Members
GEORGE R. ROBERTSHENRY R. KRAVISKKR & CO. INC.KKR ASSOCIATES HCSG L.P.KKR GROUP HOLDINGS CORP.KKR GROUP PARTNERSHIP L.P.KKR HCSG GP LLCKKR HEALTH CARE STRATEGIC GROWTH FUND L.P.KKR MANAGEMENT LLP

Document Format Files

Seq Description Document Type Size
1 SC 13D brhc10024205_sc13d.htm SC 13D 375314
2 EXHIBIT A brhc10024205_ex99-a.htm EX-99.A 23175
3 EXHIBIT B brhc10024205_ex99-b.htm EX-99.B 9213
4 EXHIBIT D brhc10024205_ex99-d.htm EX-99.D 34290
  Complete submission text file 0001140361-21-016449.txt   443927
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL NEUROPHARMA INC (Subject) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92517 | Film No.: 21903244
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019
Business Address C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 (212) 750-8300
KKR Iris Investors LLC (Filed by) CIK: 0001857860 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D